Location: New York, NY
CIK: 0002081668 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 14, 2026
Total Value ($000): $172,764 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BCAX | ZENAS BIOPHARMA, INC. | 2,388,150 (+89.1%) | $46,688 (+1.8%) | 27.0% | $16.71 | -2.5% | COM | 055477103 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BHVN | BIOHAVEN LTD | 2,936,507 | $24,843 | 14.4% | $12.39 | -5.1% | COM | G1110E107 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 3,846,154 | $36,615 | 21.2% | $7.23 | -3.2% | COM | 09058V103 |
| CYTK | CYTOKINETICS, INC | 980,392 | $64,618 | 37.4% | $62.21 | +3.6% | COM | 23282W605 |